Log In
BCIQ
Print this Print this
 

M4 PAM

  Manage Alerts
Collapse Summary General Information
Company Addex Therapeutics Ltd.
DescriptionPositive allosteric modulator of muscarinic acetylcholine receptor M4
Molecular Target Muscarinic acetylcholine receptor M4 (CHRM4) (HM4)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today